The Institute, formerly the Philippine Eye Research Institute (PERI) adheres to the University of the Philippines Commitment to the promotion of national eye health and prevention of blindness through research. The Institute was established by Republic Act No. 4593 in 1965 as the center for the advancement of ophthalmology in the country.

Objectives:

1.    Build leadership and preeminence in ophthalmic research.

·         Become the lead institution for ophthalmic research in the Philippines as mandated by RA 4593

·         Become the authority in ophthalmic research data in the Philippines

·         Become a regional collaborating center for ophthalmic research

2.    Provide research support facilities for ophthalmic research.

3.    Initiate population-based studies to define national state of ophthalmic health.

4.    Formulate recommend national policies to promote visual health, prevent eye diseases, reduce blindness and foster visual rehabilitation.

5.    Assist in patient diagnosis and treatment using the Institute’s research and clinical facilities.

6.    Provide direction, inspiration and training for the development of future research programs in ophthalmology.

Research Programs:

The research programs of the Institute are formulated primarily to provide directions in ophthalmic research. Priority programs are to be identified by the Director and its research staff depending on current research thrusts of the institute and university and availability of resources.

These are as follows:

1.    Clinical Programs in Collaboration with DOVS and Translational Clinical Research Programs.

2.    Epidemiology and Public Health Programs.

3.    Experimental and Basic Research Programs.

Research Projects:

-Ongoing

1.    Factors that lead to the delayed diagnosis of retinoblastoma.

2.    Comparative study of the commercially prepared sensitivity discs and filter paper disc.

3.    Philippine eye disease study 2012.

4.    Factors associated with risk determination in ethical reviews.

5.    Factors affecting approval process in ethical reviews.

6.    Flourescein angiography parameters in Filipinos.

7.    Silicon oil in vitreoretinal discs.

8.    Endpoints in the treatment of diabetic retinopathy.

9.    Utility of local antibiotics impregnated discs in C&S.

10. ROP prevalence in a tertiary care hospital.

11. Five year accumulated of pathologic organisms in eye infections from IO (2005-2010).

12. Lacrimal gland tumor review.

13. Immunostaining of orbital lymph node tumor.

14. Neural sheath tumor review.

15. Introduction to ophthalmic pathology.

16. Histopathologic atlas of ocular diseases.

17. Occurrence of multi-drug resistance organisms in Pasig river, manila, Philippines.

18. Antimicrobial resistance enterococcus HLAR isolated from the Pasig river of the Philippines.

Research Projects:

-New (2011-2012)

1.    Stakeholder and Activity Map for Nutrition Security.

2.    The Asia Cornea Society Infectious Keratitis Study (ACSIKS).

3.    Avastin Multidose Study.

4.    Retinoblastoma in a Major Eye Referral Center in the Philippines: Patient survival and Globe survival.

5.    Emergence of antimicrobial resistant MRSA in Light Rail Transit from the Philippines.

6.    Contact Lens Solutions related Ocular Pathogen.

7.    Quantitative Analysis of S. mutans Adherence to Orthodontic Materials Treated with Cefylpridium Chloride Mouthwash: An Experimental In Vitro Study.

Director

Dr. Leo DP. Cubillan

Assistant Director

Dr. Patricia Khu

University Researchers

Full Time

1.    Dr. Leo Cubillan

2.    Dr. Rafael Valenzuela

3.    Lilibeth Manganip

Part Time

1.    Dr. Jesus Marin

2.    Dr. Jose David Marin, Jr.

3.    Dr. Patricia Khu

4.    Dr. Yasmyne Ronquillo (on leave)

Without compensation

1.    Dr. Rolando Enrique Domingo

University Research Associates

Evangeline Abendiano

Rolando Castro

Ryan Oliver Alba

Administrative Officer

Celia Mendoza

Administrative Staff Members

Leonides Litiatco

Jose Litonjua

Armando Salonga

Cloyd Pitoc

Augusto Vocal

Roslyn Rodriguez (on Special Detail)